MedGenome Press Releases

• Published on September 25, 2019 - 17:10 GMT

  

  Dr. Andrew Peterson joins MedGenome as Chief Scientific Officer

  Key appointment to strengthen company’s leadership in leveraging South Asian cohorts and genomics for drug discovery FOSTER CITY, CALIFORNIA, UNITED STATES, September 25, 2019 /⁨EINPresswire.com⁩/ -- MedGenome, a genomics-driven research and diagnostics …

  Distribution channels: Business & Economy, Companies ...
• Published on August 27, 2019 - 18:28 GMT

  

  AntlerA leverages precision-engineered protein therapeutic platform to harness body’s regenerative potential

  AntlerA Therapeutics, a University of Toronto startup, is transforming the science and development of regenerative medicine therapies SAN FRANCISCO, CALIFORNIA, UNITED STATES, August 27, 2019 /⁨EINPresswire.com⁩/ -- AntlerA is leveraging a precision- …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on October 29, 2018 - 17:31 GMT

  

  Study identifies a targetable lung cancer mutation

  Study was published in Cancer Cell FOSTER CITY, CALIFORNIA, UNITED STATES, October 29, 2018 /⁨EINPresswire.com⁩/ -- Scientists from MedGenome, Bangalore, India in collaboration with oncologists from Tata Memorial Hospital, Mumbai, India and scientists at …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on August 21, 2018 - 17:36 GMT

  

  MedGenome’s study suggests a personalized cancer vaccine approach to treat Lynch Syndrome

  MedGenome’s recent paper "A cancer vaccine approach for personalized treatment of Lynch Syndrome" is published in Scientific Reports FOSTER CITY, CALIFORNIA, UNITED STATES, August 21, 2018 /⁨EINPresswire.com⁩/ -- The published study examines the …

  Distribution channels: Business & Economy, Chemical Industry ...
• Published on February 24, 2018 - 10:14 GMT

  MedGenome Presents its Cancer Vaccine Approach for Lynch Syndrome Patients

  MedGenome presented a poster on its study of potential cancer vaccines for Lynch Syndrome patients SAN FRANCISCO, CALIFORNIA, UNITED STATES, February 24, 2018 /⁨EINPresswire.com⁩/ -- Attendees at the 2018 Molecular Medicine Tri-Conference heard MedGenome, …

  Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
• Published on March 13, 2017 - 17:45 GMT

  

  MedGenome to discuss novel algorithm for neo-epitope prediction at the AACR Annual Meeting 2017 in Washington D.C.

  Poster titled “A novel algorithm to identify TCR-binding somatic mutations from human cancers” will be presented at AACR 2017 FOSTER CITY, CA, UNITED STATES, March 13, 2017 /EINPresswire.com/ -- MedGenome will be presenting a poster titled “A novel …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on February 8, 2017 - 22:54 GMT

  

  MedGenome to present insights into the impact of CD8 T-cell infiltration on patient survival

  The poster will be presented at ‘Frontiers in Cancer Immunotherapy’ conference in New York FOSTER CITY, CA, UNITED STATES, February 8, 2017 /EINPresswire.com/ -- MedGenome will present a poster titled “Tumor microenvironment analysis provides insights …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
• Published on January 9, 2017 - 11:13 GMT

  

  Michael A. Nemzek appointed as MedGenome Chief Commercial Officer

  Key appointment to strengthen company’s expansion efforts FOSTER CITY, CA, UNITED STATES, January 9, 2017 /EINPresswire.com/ -- MedGenome, a genomics-driven research and diagnostics company based in Foster City, California, today announced the appointment …

  Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
• Published on July 22, 2016 - 11:05 GMT

  

  MedGenome to present its tumor microenvironment analysis results at the AACR Cancer Immunotherapy Conference in New York

  The analysis compares the immune microenvironment of uveal melanoma and skin cutaneous melanoma FOSTER CITY, CALIFORNIA, UNITED STATES, July 21, 2016 /EINPresswire.com/ -- MedGenome will be presenting its analysis comparing the immune microenvironment of …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on June 5, 2016 - 10:32 GMT

  

  MedGenome partners with ZellNet Consulting to offer powerful genomics solutions in immune-oncology research

  ZellNet will be a distributor for MedGenome’s OncoPept™ – a powerful end to end genomics platform to accelerate immune-oncology research. FOSTER CITY, CA, UNITED STATES, June 4, 2016 /EINPresswire.com/ -- MedGenome announced a strategic partnership with …

  Distribution channels: Business & Economy, Companies ...
• Published on June 2, 2016 - 01:31 GMT

  

  MedGenome to highlight its tumor microenvironment analysis derived from unique gene signatures for immune cell types

  The OncoPeptTUME™ solution is a part of MedGenome’s OncoPept™ platform - an end to end genomics platform for cancer immunotherapy. FOSTER CITY, CA, UNITED STATES, June 1, 2016 /EINPresswire.com/ -- MedGenome will attend the 52nd American Society of …

  Distribution channels: Business & Economy, Companies ...
• Published on May 12, 2016 - 12:11 GMT

  

  MedGenome on tumor-cell intrinsic mechanisms that regulate infiltration of T-cells in the tumor microenvironment

  The data will be presented at the Biomarkers & Diagnostics World Congress in Philadelphia, May 16-19, 2016 FOSTER CITY, CA, UNITED STATES, May 12, 2016 /EINPresswire.com/ -- MedGenome provides customized genomic solutions in cancer immunotherapy to …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on April 29, 2016 - 14:30 GMT

  

  MedGenome announces free access to OncoPeptTOPE™, its proprietary database of neo-antigens and neo-epitopes

  OncoPeptTOPE™ is freely accessible online to DNA / Peptide vaccine researchers FOSTER CITY, CA, UNITED STATES, April 29, 2016 /EINPresswire.com/ -- MedGenome recently announced that its proprietary OncoPeptTOPE™ database of neo-antigens and neo-epitopes …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
• Published on April 12, 2016 - 18:32 GMT

  

  MedGenome study analyzing Wellderley data shows interesting trend on gene mutations associated with cardiac function

  FOSTER CITY, CA, UNITED STATES, April 12, 2016 /EINPresswire.com/ -- MedGenome will present results from its analysis of the whole genome sequence data from the Wellderly study (Scripps Translational Science Institute) at the Diabetes Summit 2016, from …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on March 30, 2016 - 09:59 GMT

  

  MedGenome to present on OncoMD, a genomics data analysis and interpretation platform, for cancer discovery research

  The MedGenome proprietary platform, currently leveraged by various commercial and academic collaborators in the US, will be presented at AACR 2016. FOSTER CITY, CALIFORNIA, UNITED STATES, March 30, 2016 /EINPresswire.com/ -- MedGenome will present an …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
• Published on February 15, 2016 - 10:36 GMT

  MedGenome to discuss its proprietary cancer immunotherapeutics platform at the San Diego conference

  The posters will be presented at the NGS Data Analysis and Informatics Conference, February 18–19, 2016 in San Diego, CA SAN FRANCISCO, CA, UNITED STATES, February 15, 2016 /EINPresswire.com/ -- MedGenome announced today that they will present 2 posters …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...